Featured Posts

Neglecting your eyes can influence dementia Elderly people with untreated poor vision are significantly more likely to suffer from Alzheimer’s disease and other forms of dementia than their clear-sighted counterparts, according to a study published...

Readmore

Blueberry juice improves memory A new study shows that drinking a daily dose of wild blueberry juice improved the memory of older adults with age-related memory problems. It's the first study to show this potential benefit of blueberries...

Readmore

Pump up your hippo for a better functioning brain The role of some brain structures are better understood than others. For example, the hippocampus, a small S-shaped structure that lies just inside your temples, plays a specific role in memory for facts,...

Readmore

Australian research shows key to healthy brain aging. Use it or lose it! Pilot study by Alzheimers Australia (WA) finds regular brain exercises are the key to healthy ageing Just two hours of brain exercises a week can markedly improve a person’s...

Readmore

Higher leptin levels, lower Alzheimer's incidence Persons with higher levels of leptin, a protein hormone produced by fat cells and involved in the regulation of appetite, may have an associated reduced incidence of Alzheimer disease and dementia, according...

Readmore

Myfitbrain Rss

Alzheimer’s Disease: New Small Molecule Approach To Treatment

Posted by Jim Hanekamp | Posted in Aging, Alzheimer's, Dementia, Hippocampus | Posted on 13-06-2009

0

ScienceDaily (Apr. 18, 2009) — New therapeutic approaches in Alzheimer’s disease are urgently needed. Work led by Professor Mark Pepys FRS over more than 20 years has identified a protein known as serum amyloid P component (SAP) as a possible therapeutic target in Alzheimer’s disease. In collaboration with Roche he developed a new small molecule drug, CPHPC, which specifically targets SAP and removes it from the blood.

In the exciting new work reported now in the PNAS, the Pepys team together with Professor Martin Rossor and colleagues from the Dementia Research Centre of UCL’s Institute of Neurology, have shown that the drug also removes SAP from the brains of patients with Alzheimer’s disease.
Read the rest of this article by clicking the following link: Alzheimer’s Disease

  • Facebook
  • Twitter
  • FriendFeed
  • Gmail
  • LinkedIn
  • MySpace
  • Plaxo Pulse
  • Share/Bookmark

Write a comment